Insulet PODD
NASDAQ PODD
$134.51 -3.41 (-2.47%)
As of: Sep 10, 2026 · 2:53 PM EDT

Insulet (PODD) Total Current Liabilities (2010 - 2026)

Insulet's (PODD) quarterly Total Current Liabilities came in at $744.2 million in Q2 2026, down 26.32% on a YoY basis from $1.0 billion in Q2 2025, and up 8.25% quarter-over-quarter from $687.5 million in Q1 2026.

Analysis

Insulet (PODD) Total Current Liabilities (2010 - 2026) Analysis & Trends

Insulet (PODD) has reported Total Current Liabilities for 17 consecutive years, with $744.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Current Liabilities fell 26.32% year-over-year to $744.2 million; the trailing twelve-month figure through Jun 2026 stood at $744.2 million (down 26.32% YoY), and the FY2025 full-year result was $680.1 million, up 28.71% from the prior year.
  • Total Current Liabilities advanced to $744.2 million in Q2 2026 per PODD's latest filing, from $687.5 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $1.0 billion in Q2 2025 and bottomed at $215.0 million in Q1 2022.
  • Historically, Total Current Liabilities has averaged $508.2 million across 5 years, with a median of $468.7 million in 2023.
  • The sharpest annual moves came in 2025 and 2026: Total Current Liabilities jumped 107.84% in 2025, then slipped 26.32% in 2026.
  • Over 5 years, Total Current Liabilities stood at $364.7 million in 2022, then gained by 23.72% to $451.2 million in 2023, then increased by 17.11% to $528.4 million in 2024, then increased by 28.71% to $680.1 million in 2025, then rose by 9.43% to $744.2 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $744.2 million, $687.5 million, and $680.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Abbott Laboratories 180.76 Bn 175.16 Bn 7.27 Bn 17.81 Bn
2 Intuitive Surgical 127.77 Bn 122.55 Bn 1.96 Bn 1.92 Bn
3 Medtronic 117.20 Bn 108.39 Bn 6.34 Bn 11.80 Bn
4 Stryker 104.01 Bn 100.53 Bn 4.50 Bn 6.68 Bn
5 Boston Scientific 63.51 Bn 62.97 Bn 3.85 Bn 6.43 Bn
6 Edwards Lifesciences 49.80 Bn 45.55 Bn 1.35 Bn 1.51 Bn
7 Alcon 33.03 Bn 31.58 Bn 1.68 Bn 3.17 Bn
8 Dexcom 32.18 Bn 30.23 Bn 830.00 Mn 2.36 Bn
9 Steris 20.71 Bn 20.23 Bn 684.20 Mn 1.28 Bn
10 Insulet 9.35 Bn 8.82 Bn 562.60 Mn 744.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 744.20 Mn
Mar 31, 2026 687.50 Mn
Dec 31, 2025 680.10 Mn
Sep 30, 2025 647.70 Mn
Jun 30, 2025 1.01 Bn
Mar 31, 2025 520.40 Mn
Dec 31, 2024 528.40 Mn
Sep 30, 2024 506.20 Mn
Jun 30, 2024 486.00 Mn
Mar 31, 2024 432.40 Mn
Dec 31, 2023 451.20 Mn
Sep 30, 2023 451.40 Mn
Jun 30, 2023 425.00 Mn
Mar 31, 2023 383.30 Mn
Dec 31, 2022 364.70 Mn
Sep 30, 2022 334.20 Mn
Jun 30, 2022 279.30 Mn
Mar 31, 2022 215.00 Mn
Dec 31, 2021 228.80 Mn
Sep 30, 2021 228.60 Mn